When Green Stools Require Medical Attention Whilst green stools are usually benign in patients taking Mounjaro, certain accompanying symptoms warrant prompt medical evaluation
Rapid weight loss, low protein intake, and low resistance training increase those risks
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
Here are a few tips to help you monitor results and stay motivated: Weekly weigh-ins Checking your weight once a week can help you notice patterns and understand how the treatment is working for you
When combined with clinical markers and lifestyle factors, genetic context helps build a more complete picture of your metabolic profile
The FDA determined that the tirzepatide shortage was resolved on December 19, 2024, following reevaluation